Pennsylvania Sen. Bob Casey is invested, through several mutual funds, in the same Chinese fentanyl manufacturer that he recently claimed a company that was led by Republican candidate Dave McCormick was 'profiting off people's pain' by investing in. The senator's campaign claimed McCormick 'saw a way to get even richer' in the fentanyl crisis, in an ad released earlier this month slamming the company he led, Bridgewater Associates, for investing in Humanwell.
' Casey is also invested through mutual funds in Jiangsu Nhwa Pharmaceutical and Sinopharm Group, which are similarly involved in the manufacturing and wholesale of Chinese narcotics, respectively. 'FEEL BETRAYED': TOP CONSERVATIVE GROUP BLASTS VULNERABLE DEMS ON INFLATION IN MULTIMILLION-DOLLAR AD BLITZ': Humanwell, as a pharmaceutical manufacturing company, produces medical-grade opiates. It is not one of the Chinese companies that has been singled out by the U.S.